FH and cancer: Most cancers show evidence of aerobic glycolysis, and in several kidney cancers, a deficiency in aerobic respiration appears to be selected for by genetic mutation (e.g. FH mutations in FH-RCC or Complex I mutations in renal oncocytoma).